BioNTech, Pfizer say they expect to have COVID-19 vaccine data for young children this quarterMarket Watch • 04/27/22
BioNTech, Pfizer seek FDA authorization of a COVID-19 booster for young childrenMarket Watch • 04/27/22
BioNTech to Report First Quarter 2022 Financial Results and Operational Update on May 9, 2022GlobeNewsWire • 04/26/22
Pfizer (PFE), BioNTech (BNTX) COVID Booster Effective in Young KidsZacks Investment Research • 04/18/22
Pfizer/BioNTech Fourth COVID-19 Vaccine Dose Protects Against Omicron For At Least One MonthBenzinga • 04/18/22
Pfizer and BioNTech say data shows high immune response for COVID booster in children aged 5 to 11Market Watch • 04/14/22
Pfizer and BioNTech Announce Data Demonstrating High Immune Response Following a Booster Dose of their COVID-19 Vaccine in Children 5 Through 11 Years of AgeBusiness Wire • 04/14/22
BioNTech and Matinas BioPharma Announce Exclusive Research Collaboration to Evaluate Novel Delivery Technology for mRNA-based VaccinesGlobeNewsWire • 04/11/22
BioNTech Presents Positive Preliminary Phase 1/2 Data for First-in-Class CAR-T Program BNT211 at AACRGlobeNewsWire • 04/11/22
BioNTech Granted Pandemic Preparedness Contract by German Federal Ministry of HealthGlobeNewsWire • 04/08/22
Pfizer/BioNTech's Second COVID-19 Vaccine Booster Provides Short-Lived Protection In Elderly, Israel Study ShowsBenzinga • 04/06/22